Micahel LeRoy | Florida

About Us

Michael LeRoy, a founder and the managing partner at the law firm of Fulmer, LeRoy, Albee, Baumann is proud that March 1, 2014 will mark the firm’s seventh Anniversary. Michael LeRoy of Florida graduated among the top of his class from Florida State University College of Law in 1993. In 1993, Michael LeRoy of Florida was admitted to the Florida State Bar. Michael LeRoy joined the Trial Lawyers Division of the Florida Bar in 1997.

Throughout his career, Michael LeRoy, has been a widely sough-after trial attorney. Michael LeRoy of Florida is well respected by his peers in the Florida state legal system. Prior to founding Fulmer, LeRoy, Albee, Baumann, Michael LeRoy worked for many years in the United States District Court System of Florida.

Michael LeRoy Florida

Michael LeRoy of Florida has never let his professional successes distract him from his true passion in life: philanthropy. Michael LeRoy loves working with charitable organizations to inspire communities and people to improve their lives and the lives of others. Michael LeRoy of Florida has, for years, assisted a number of organizations, including Habitat for Humanity, the ALS Foundation, Team Gleason, the Friends in Need Foundation, and Make It Right Nola.

Recently, Michael LeRoy has devoted even more time and effort to working with the ALS Foundation and related organizations. These organizations work to find a cure for ALS, educate the public about the disease, and support those who are currently managing the challenges of life with ALS.

ALS is more commonly known as “Lou Gehrig’s Disease.” It can affect people of all ages but is a more commonly found in those in the age range of 40-70. ALS is also slightly more prevalent amongst men than women and currently has no known cure. It is a progressive, degenerative disease and, in most cases, is ultimately fatal.

Michael LeRoy of Florida was impressed by the fortitude and mission of the Team Gleason organization and is proud to assist them to be part of the fight to eliminate ALS from the world.